The Meeting of the Transparency Council No. 38/2022 of 26.09.2022

The agenda includes:

Preparing a position on the assessment of the legitimacy of the inclusion of the procedure ,,Transcatheter repair of tricuspid regurgitation by the edge-to-edge method using a clip” in the list of guaranteed highly specialised inpatient services.

Preparing a position on the evaluation of the drug: Ocaliva (acidum obeticholicum) under the drug programme “Treatment of primary biliary cholangitis (ICD 10: K74.3)”.

Preparing an opinion on recommended health technologies, activities carried out within the framework of health policy programmes and the conditions for their implementation in the scope of prevention of thyroid diseases.